Fivespan Partners, LP has made a notable filing with the SEC, reporting ownership changes involving Dylan G. Haggart. This event is significant as it sheds light on the firm's investment management activities and its relationship with Stride, Inc., a company in the educational services sector.
Fivespan Partners, LP is a Delaware limited partnership based in San Francisco, California. The firm is primarily engaged in investment management, and its recent filings indicate active participation in the financial markets. The latest Form 3 was filed on October 27, 2026, following a series of other filings, including Form 4 on the same day and several 13F-HR forms earlier in the year.
What the Filing Says
The SEC filing reveals that Dylan G. Haggart is a director of Stride, Inc., which is identified as the issuer of the securities in question. The filing notes that Haggart, along with Fivespan Partners, LP, is deemed to be the beneficial owner of certain securities reported in the Form 3. Notably, the filing states, "In addition to Dylan G. Haggart, this Form 3 is being filed jointly by Fivespan Partners, LP... which may be deemed to be the beneficial owner of certain of the securities reported on this Form 3."
Impact
This ownership change may influence various stakeholders, including investors and analysts monitoring the educational services sector. The filing indicates that Fivespan Partners, LP, through its managing partner Haggart, is actively involved in the governance of Stride, Inc., which could impact strategic decisions within the company.
What's Next
The filing does not specify what happens next regarding these ownership changes. However, it does indicate that the joint filing agreement among the reporting persons remains in effect until revoked.
Read Next
Talos Energy sees major stock sale by Control Empresarial
Fivespan Partners Reports Major Stock Purchases by Haggart
Studio City International updates ownership filings amid changes
John C. Ivascu Sells 4,800 Shares of Forum Energy Technologies
ADAR1 Capital Management Increases Stake in NextCure, Inc.
Gibbs David W files Form 3, reveals ownership in Amgen








